Can-Fite BioPharma Ltd.
TASE:CANF
0.03
₪0.00 (0.00%)
0.03
₪0.00 (0.00%)
End-of-day quote: 05/06/2024

CANF - Can-Fite BioPharma Stock Prediction 2025 - 2030

18 years of reliable Can-Fite BioPharma stock forecast. The Wall Street analysts predict Outperform for CANF. See at a glance whether TASE:CANF will rise in the future.

₪0.00
Forecast 2023
₪0.03
Forecast 2025
₪0.05
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
₪0.00
Forecast 2025
₪0.03
Forecast 2030
₪0.05
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.91
Price-to-book Ratio
N/A
Market Cap
0.05B
TEV
0.08 B
Dividend
₪0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
₪0.00
Country

Can-Fite BioPharma Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Can-Fite BioPharma Stock Forecast 2023

₪0.00

In the last five quarters, Can-Fite BioPharma’s Price Target has risen from ₪0.00 to ₪0.03 - a 100% increase. Two analysts predict that Can-Fite BioPharma’s share price will fall in the coming year, reaching ₪0.00. This would represent a decrease of -100%.

-100%
-100
Last update: 05/07/2024

Highest Price Target ₪0.00

Average Price Target ₪0.00

Lowest Price Target ₪0.00

Can-Fite BioPharma Stock Forecast 2025

Stock Prediction for the Price of One Can-Fite BioPharma Share in Jan 2025.

In Jan 2025 analysts predict a share price of ₪0.03. An increase of 6.92% compared to today's share price.

Stock Prediction for the Price of One Can-Fite BioPharma Share in Feb 2025.

In Feb 2025 analysts predict a share price of ₪0.03. An increase of 7.75% compared to today's share price.

Stock Prediction for the Price of One Can-Fite BioPharma Share in Mar 2025.

In Mar 2025 analysts predict a share price of ₪0.03. An increase of 8.57% compared to today's share price.

Stock Prediction for the Price of One Can-Fite BioPharma Share in Apr 2025.

In Apr 2025 analysts predict a share price of ₪0.03. An increase of 9.4% compared to today's share price.

Stock Prediction for the Price of One Can-Fite BioPharma Share in May 2025.

In May 2025 analysts predict a share price of ₪0.03. An increase of 10.23% compared to today's share price.

Stock Prediction for the Price of One Can-Fite BioPharma Share in Jun 2025.

In Jun 2025 analysts predict a share price of ₪0.03. An increase of 11.06% compared to today's share price.

Stock Prediction for the Price of One Can-Fite BioPharma Share in Jul 2025.

In Jul 2025 analysts predict a share price of ₪0.03. An increase of 11.88% compared to today's share price.

Stock Prediction for the Price of One Can-Fite BioPharma Share in Aug 2025.

In Aug 2025 analysts predict a share price of ₪0.03. An increase of 12.71% compared to today's share price.

Stock Prediction for the Price of One Can-Fite BioPharma Share in Sep 2025.

In Sep 2025 analysts predict a share price of ₪0.03. An increase of 13.54% compared to today's share price.

Stock Prediction for the Price of One Can-Fite BioPharma Share in Oct 2025.

In Oct 2025 analysts predict a share price of ₪0.03. An increase of 14.37% compared to today's share price.

Stock Prediction for the Price of One Can-Fite BioPharma Share in Nov 2025.

In Nov 2025 analysts predict a share price of ₪0.03. An increase of 15.19% compared to today's share price.

Stock Prediction for the Price of One Can-Fite BioPharma Share in Dec 2025.

In Dec 2025 analysts predict a share price of ₪0.03. An increase of 16.02% compared to today's share price.

Can-Fite BioPharma Stock Predictions 2030

Can-Fite BioPharma Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of ₪0.05. An increase of 67.24% compared to the previous month's estimate.

Can-Fite BioPharma Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of ₪0.05. An increase of 68.54% compared to the previous month's estimate.

Can-Fite BioPharma Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of ₪0.05. An increase of 69.83% compared to the previous month's estimate.

Can-Fite BioPharma Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of ₪0.05. An increase of 71.13% compared to the previous month's estimate.

Can-Fite BioPharma Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of ₪0.05. An increase of 72.42% compared to the previous month's estimate.

Can-Fite BioPharma Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of ₪0.05. An increase of 73.71% compared to the previous month's estimate.

Can-Fite BioPharma Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of ₪0.05. An increase of 75.01% compared to the previous month's estimate.

Can-Fite BioPharma Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of ₪0.05. An increase of 76.3% compared to the previous month's estimate.

Can-Fite BioPharma Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of ₪0.05. An increase of 77.6% compared to the previous month's estimate.

Can-Fite BioPharma Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of ₪0.05. An increase of 78.89% compared to the previous month's estimate.

Can-Fite BioPharma Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of ₪0.05. An increase of 80.19% compared to the previous month's estimate.

Can-Fite BioPharma Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of ₪0.05. An increase of 81.48% compared to the previous month's estimate.

P/E
0.00
Beta
0.91
Price-to-book Ratio
N/A
Market Cap
0.05B
TEV
0.08 B
Dividend
₪0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
₪0.00
Country

Can-Fite BioPharma Analyst Ratings Frequently Asked Questions

Who are the analysts watching Can-Fite BioPharma Ltd.?

The following analysts have recently covered Can-Fite BioPharma:

H.C. Wainwright & Co.
Alliance Global Partners
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Can-Fite BioPharma Ltd.?

The following sell-side analysts have recently covered Can-Fite BioPharma:

Bernardino, Vernon Tolentino
Molloy, James Francis
(This information refers to the last 90 days.)